secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2024-12-18T23:59:59+00:00
Accession:  0001193805-24-001496
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Daniel Vitt enters new employment agreement for temporary US relocation; board role at Immunic AG paused
--------------------------------------------------------------------------------

- Employment agreement effective Dec 16, 2024 for CEO's planned <1 year US relocation; board role at Immunic AG suspended.
- Base salary $610,000/yr, target annual bonus 55% of salary, eligible for equity awards under existing plan.
- Monthly housing reimbursement up to $100,000 during US relocation, plus standard benefits and COBRA continuation.
- Severance: 12 months' salary on non-cause/good reason termination (outside change-of-control) if release executed; 18 months if within change-of-control period.
- Suspension agreement dated Dec 18, 2024 pauses Immunic AG service agreement until reappointment; no remuneration during suspension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524001496/0001193805-24-001496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380524001496/e664091_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-001496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer